ABEONA THERAPEUTICS INC. Earnings Per Share (Basic)
ABEONA THERAPEUTICS INC. (ABEO) reported Earnings Per Share (Basic) of -$0.35 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-13
- ABEONA THERAPEUTICS INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.35, a 116.91% decline year-over-year.
- ABEONA THERAPEUTICS INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.30.
- ABEONA THERAPEUTICS INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.10.
- ABEONA THERAPEUTICS INC. earnings per share, basic for the quarter ending 2025-06-30 was $2.07, a 989.47% increase year-over-year.
- ABEONA THERAPEUTICS INC. earnings per share, basic for fiscal 2025 was $1.34.
- ABEONA THERAPEUTICS INC. earnings per share, basic for fiscal 2024 was -$1.55.
- ABEONA THERAPEUTICS INC. earnings per share, basic for fiscal 2023 was -$2.53.
- ABEONA THERAPEUTICS INC. earnings per share, basic for fiscal 2022 was -$5.53.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.35 10-Q · filed 2026-08-13 | -$0.66 10-Q · filed 2026-08-13 | ||||||
| 2026-03-31 | -$0.30 10-Q · filed 2026-05-13 | |||||||
| 2025-12-31 | $1.34 10-K · filed 2026-03-17 | |||||||
| 2025-09-30 | -$0.10 10-Q · filed 2025-11-12 | $1.76 10-Q · filed 2025-11-12 | ||||||
| 2025-06-30 | $2.07 10-Q · filed 2026-08-13 | $1.89 10-Q · filed 2026-08-13 | ||||||
| 2025-03-31 | -$0.24 10-Q · filed 2026-05-13 | -$0.43 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$1.05 derived: net income ÷ weighted average shares · filed 2026-05-13 | -$0.95 derived: net income ÷ weighted average shares · filed 2026-05-13 | ||||
| 2024-12-31 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-03-17 | -$0.82 derived: net income ÷ weighted average shares · filed 2026-03-17 | -$0.70 derived: net income ÷ weighted average shares · filed 2026-03-17 | -$1.55 10-K · filed 2026-03-17 | ||||
| 2024-09-30 | -$0.63 10-Q · filed 2025-11-12 | -$0.52 derived: net income ÷ weighted average shares · filed 2025-11-12 | -$1.41 10-Q · filed 2025-11-12 | -$2.01 derived: net income ÷ weighted average shares · filed 2025-11-12 | ||||
| 2024-06-30 | $0.19 10-Q · filed 2025-08-14 | -$0.72 10-Q · filed 2025-08-14 | -$1.32 derived: net income ÷ weighted average shares · filed 2025-08-14 | -$1.79 derived: net income ÷ weighted average shares · filed 2025-08-14 | ||||
| 2024-03-31 | -$1.16 10-Q · filed 2025-05-15 | -$1.82 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$2.31 derived: net income ÷ weighted average shares · filed 2025-05-15 | -$3.20 derived: net income ÷ weighted average shares · filed 2025-05-15 | ||||
| 2023-12-31 | -$0.65 derived: net income ÷ weighted average shares · filed 2025-03-20 | -$1.13 derived: net income ÷ weighted average shares · filed 2025-03-20 | -$1.97 derived: net income ÷ weighted average shares · filed 2025-03-20 | -$2.53 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | -$0.48 10-Q · filed 2024-11-14 | -$1.33 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$1.89 10-Q · filed 2024-11-14 | -$2.45 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2023-06-30 | -$0.92 10-Q · filed 2024-08-12 | $0.92 10-Q · filed 2023-08-08 | -$1.48 10-Q · filed 2024-08-12 | $1.48 10-Q · filed 2023-08-08 | -$2.04 derived: net income ÷ weighted average shares · filed 2024-08-12 | -$2.87 derived: net income ÷ weighted average shares · filed 2024-08-12 | ||
| 2023-03-31 | -$0.54 10-Q · filed 2024-05-15 | -$1.07 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$1.85 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$2.87 derived: net income ÷ weighted average shares · filed 2024-05-15 | ||||
| 2022-12-31 | -$0.53 derived: net income ÷ weighted average shares · filed 2024-03-18 | -$1.37 derived: net income ÷ weighted average shares · filed 2024-03-18 | -$2.51 derived: net income ÷ weighted average shares · filed 2024-03-18 | -$5.53 10-K · filed 2024-03-18 | ||||
| 2022-09-30 | -$1.00 10-Q · filed 2023-11-13 | -$1.48 10-Q · filed 2022-11-14 | -$2.34 derived: net income ÷ weighted average shares · filed 2023-11-13 | -$6.05 10-Q · filed 2023-11-13 | -$7.05 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $1.36 10-Q · filed 2023-08-08 | -$2.08 10-Q · filed 2022-08-11 | $5.16 10-Q · filed 2023-08-08 | -$5.67 10-Q · filed 2022-08-11 | ||||
| 2022-03-31 | -$3.80 10-Q · filed 2023-05-11 | -$0.14 10-Q · filed 2022-05-13 | ||||||
| 2021-12-31 | -$11.14 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$13.24 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$17.26 derived: net income ÷ weighted average shares · filed 2023-03-29 | -$21.57 10-K · filed 2023-03-29 | ||||
| 2021-09-30 | -$1.80 10-Q · filed 2022-11-14 | -$5.71 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$9.93 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | -$3.93 10-Q · filed 2022-08-11 | -$8.18 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | -$0.17 10-Q · filed 2022-05-13 | |||||||
| 2016-12-31 | -$0.64 derived: net income ÷ weighted average shares · filed 2017-03-30 | |||||||
| 2015-12-31 | -$0.53 derived: net income ÷ weighted average shares · filed 2017-03-30 | |||||||
| 2014-12-31 | -$2.04 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$4.41 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$2.56 derived: net income ÷ weighted average shares · filed 2016-03-30 | -$15.26 10-K · filed 2015-03-31 | ||||
| 2014-09-30 | -$4.15 10-Q · filed 2014-11-14 | -$1.16 derived: net income ÷ weighted average shares · filed 2015-11-16 | -$32.46 10-Q · filed 2014-11-14 | -$1.42 derived: net income ÷ weighted average shares · filed 2015-11-16 | ||||
| 2014-06-30 | -$0.51 10-Q · filed 2014-08-14 | -$0.57 10-Q · filed 2014-08-14 | -$0.95 derived: net income ÷ weighted average shares · filed 2015-08-14 | -$1.32 derived: net income ÷ weighted average shares · filed 2015-08-14 | ||||
| 2014-03-31 | -$0.03 10-Q · filed 2014-05-12 | -$0.25 derived: net income ÷ weighted average shares · filed 2015-05-14 | -$0.47 derived: net income ÷ weighted average shares · filed 2015-05-14 | -$0.26 derived: net income ÷ weighted average shares · filed 2015-05-14 | ||||
| 2013-12-31 | -$3.46 derived: net income ÷ weighted average shares · filed 2015-03-31 | -$5.23 derived: net income ÷ weighted average shares · filed 2015-03-31 | -$0.21 derived: net income ÷ weighted average shares · filed 2015-03-31 | $3.07 10-K · filed 2015-03-31 | $0.06 10-K · filed 2014-03-26 | |||
| 2013-09-30 | -$1.77 10-Q · filed 2014-11-14 | -$0.04 10-Q · filed 2013-11-14 | -$0.00 derived: net income ÷ weighted average shares · filed 2014-11-14 | $6.61 10-Q · filed 2014-11-14 | $0.13 10-Q · filed 2013-11-14 | $1.20 derived: net income ÷ weighted average shares · filed 2014-11-14 | ||
| 2013-06-30 | $0.03 10-Q · filed 2014-08-14 | $0.17 10-Q · filed 2014-08-14 | $0.94 derived: net income ÷ weighted average shares · filed 2014-08-14 | $0.33 derived: net income ÷ weighted average shares · filed 2014-08-14 | ||||
| 2013-03-31 | $0.14 10-Q · filed 2014-05-12 | $0.92 derived: net income ÷ weighted average shares · filed 2014-05-12 | $0.29 derived: net income ÷ weighted average shares · filed 2014-05-12 | -$0.16 derived: net income ÷ weighted average shares · filed 2014-05-12 | ||||
| 2012-12-31 | $0.79 derived: net income ÷ weighted average shares · filed 2014-03-26 | $0.16 derived: net income ÷ weighted average shares · filed 2014-03-26 | -$0.30 derived: net income ÷ weighted average shares · filed 2014-03-26 | -$0.52 10-K · filed 2014-03-26 | ||||
| 2012-09-30 | -$0.63 10-Q · filed 2013-11-14 | -$1.09 derived: net income ÷ weighted average shares · filed 2013-11-14 | -$1.31 10-Q · filed 2013-11-14 | |||||
| 2012-06-30 | -$0.46 10-Q · filed 2013-08-14 | -$0.68 10-Q · filed 2013-08-14 | ||||||
| 2012-03-31 | -$0.22 10-Q · filed 2013-05-15 | |||||||
| 2011-06-30 | -$0.09 10-Q · filed 2011-08-15 | -$0.21 10-Q · filed 2011-08-15 | ||||||
| 2011-03-31 | -$0.12 10-Q · filed 2012-05-15 | |||||||
| 2010-06-30 | $0.09 10-Q · filed 2011-08-15 | $0.13 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |